地瓜视频APP免费观看下载安装_www免费视频com_AA区一区二区三无码精片_人人澡人人看_japanese熟睡侵犯

        1. <li id="43v4v"></li>

            <li id="43v4v"></li>

            Recombinant Human ENA-78/CXCL5重組人CXCL5

            更多活動更多優(yōu)惠,盡在翌圣商城》

            批量采購, 請點(diǎn)擊詢價(jià)

            產(chǎn)品說明書

            FAQ

            COA

            已發(fā)表文獻(xiàn)

            CXCL5, also known as epithelial cell-derived neutrophil-activating peptide (ENA-78), is an 8 kDa proinflammatory member of the CXC chemokine family. Its Glu-Leu-Arg (ELR) motif confers angiogenic properties and distinguishes it from ELR-CXC chemokines which are angiostatic. CXCL5 is produced following stimulation of cells with the inflammatory cytokines interleukin-1 or tumor necrosis factor-alpha. It also can be detected in eosinophils, and can be inhibited with the type II interferon. In vivo, CXCL5 is elevated at sites of inflammation and pulmonary fibrosis where it promotes neutrophil infiltration and activation as well as angiogenesis. Its up-regulation contributes to increased vascularization, tumor growth, and metastasis in many cancers. CXCL5 plays a role in reducing sensitivity to sunburn pain in some subjects, and is a potential target which can be utilized to understand more about pain in other inflammatory conditions like arthritis and cystitis. It elicits these effects by interacting with the cell surface chemokine receptor CXCR2.

             

            Product Properties

            Synonyms

            ENA-78 (5-78), CXCL5 (5-78), Neutrophil Activating Peptide ENA-78, Small-inducible cytokine B5

            Accession

            P42830

            GeneID

            6374

            Source

            E.coli-derived Human ENA-78, 5-78 aa/CXCL5, Ala41-Asn114.

            Molecular Weight

            Approximately 8.1 kDa.

            AA Sequence

            AAVLRELRCV CLQTTQGVHP KMISNLQVFA IGPQCSKVEV VASLKNGKEI CLDPEAPFLK KVIQKILDGG NKEN

            Tag

            None

            Physical Appearance

            Sterile Filtered White lyophilized (freeze-dried) powder.

            Purity

            > 97% by SDS-PAGE and HPLC analyses.

            Biological Activity

            The biological activity determined by a chemotaxis bioassay using human peripheral blood neutrophils is in a concentration of 10.0-100.0 ng/mL. Fully biologically active when compared to standard.

            Endotoxin

            < 1.0 EU per 1μg of the protein by the LAL method.

            Formulation

            Lyophilized from a 0.2 μm filtered concentrated solution in 20 mM PB, pH 7.4, 50 mM NaCl.

            Reconstitution

            We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20°C. Further dilutions should be made in appropriate buffered solutions.

             

            Shipping and Storage

            The products are shipped with ice pack and can be stored at -20℃ to -80℃ for 1 year.

            Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.

             

            Cautions

            1. Avoid repeated freeze-thaw cycles.

            2. For your safety and health, please wear lab coats and disposable gloves for operation.

            3. For research use only!

             

            HB220225

             

            400-6111-883